- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07503665
AI-assisted Fall Prevention Through Evidence (SAFE)
Safe AI-assisted Fall Prevention Through Evidence
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Project leader
- Phone Number: +46706924613
- Email: elin.siira@hh.se
Study Locations
-
-
-
Gothenburg, Sweden
- Recruiting
- Sahlgrenska Hospital
-
Contact:
- Project leader
- Phone Number: +46706924613
- Email: elin.siira@hh.se
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Individual interviews with key actors in the implementation
Inclusion criteria:
- Be employed at one of the participating hospitals
- Hold a role as a key stakeholder in the implementation work
- Have experience with the implementation of the AI-assisted fall prevention
- Have the ability to understand and communicate in Swedish
Exclusion criteria:
1. Have insufficient proficiency in Swedish to participate in an interview or observation and to understand the purpose and content of the study
Individual interviews with managers
Inclusion criteria:
- Be employed as a manager at one of the participating hospitals
- Have experience with the implementation or use of the AI-assisted fall prevention
- Have the ability to understand and communicate in Swedish
Exclusion criteria:
1. Have insufficient proficiency in Swedish to participate in an interview or observation and to understand the purpose and content of the study
Individual interviews with staff
Inclusion criteria:
- Be employed as staff on a ward at one of the participating hospitals where the AI-assisted fall prevention has been decided to be implemented
- Have experience with the implementation or use of the AI-assisted fall prevention
- Have the ability to understand and communicate in Swedish
Exclusion criteria:
1. Have insufficient proficiency in Swedish to participate in an interview or observation and to understand the purpose and content of the study
Observations of staff work
Inclusion criteria:
- Be employed as staff on a ward at one of the participating hospitals where the AI-assisted fall prevention has been decided to be implemented
- Have experience with the implementation or use of the AI-assisted fall prevention
- Have the ability to understand and communicate in Swedish
Exclusion criteria:
1. Have insufficient proficiency in Swedish to participate in an interview or observation and to understand the purpose and content of the study
Individual interviews with patients and family members:
Inclusion criteria (for family members, only inclusion criterion 1b applies):
- Either (a) have been a patient on a ward at one of the participating hospitals where the AI-assisted fall prevention has been implemented, or (b) be a family member involved in the care of a patient who meets the inclusion criteria but lacks the ability to provide informed consent. The family member must be able to understand and communicate in Swedish
- Have experience with the AI-assisted fall prevention as part of their care
- Have the ability to understand and communicate in Swedish
- Be 18 years of age or older
- Have the ability to provide informed consent. If there is any uncertainty regarding a patient's ability to provide informed consent, the research team will refrain from conducting the interview.
Exclusion criteria:
- Have insufficient proficiency in Swedish to participate in an interview or observation and to understand the purpose and content of the study
- Lack the ability to provide informed consent
Web-based surveys with staff:
Inclusion criteria:
- Be employed as staff on a ward at one of the participating hospitals where the AI-assisted fall prevention is decided to be implemented.
Exclusion criteria:
- Not being employed on a ward at one of the participating hospitals where the AI-assisted fall prevention is decided to be implemented
- Lack the ability to access information and respond to the survey in Swedish
Retrospective medical record data:
Inclusion criteria:
1. Patients who have been cared for on a ward at one of the participating hospitals where the AI-assisted fall prevention has been implemented, either (a) up to 24 months after implementation or (b) up to 12 months before implementation.
Exclusion criteria:
1. Patients who have only received care outside the defined time period, meaning not within 24 months after or 12 months before the implementation of the AI-assisted fall prevention
Learning labs:
Inclusion criteria:
- (a) Be employed at one of the participating hospitals and hold a role as a key stakeholder in the implementation work, or be staff or a manager with experience of the implementation or use of the AI-assisted fall prevention; or (b1) have been a patient cared for on a ward at one of the participating hospitals where the AI-assisted fall prevention has been implemented and have experience with the AI-assisted fall prevention as part of their care; or (b2) be a family member of a patient with such experience; or (c) be a patient representative for a patient group, patient organization, or user organization where falls are an identified issue
- Have the ability to understand and communicate in Swedish
Exclusion criteria:
- Have insufficient proficiency in Swedish to participate in an interview or observation and to understand the purpose and content of the study
- Lack the ability to provide informed consent
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Fall rate
Time Frame: From earliest January 2025 to latest December 2028
|
From earliest January 2025 to latest December 2028
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
NoMAD instrument
Time Frame: Baseline, 12 months follow up, 24 months follow up
|
The NoMAD (Normalization Measure Development) instrument is a 23-item survey used to assess how complex interventions become implemented, embedded, and integrated into everyday healthcare practice.
Grounded in Normalization Process Theory (NPT), it focuses on the collective work staff perform to make a new method part of routine care.
Twenty of the items map onto the four core NPT constructs: coherence, which concerns how staff understand and make sense of the new practice; cognitive participation, which captures the work required to engage and involve people; collective action, which reflects the practical efforts needed to enact the intervention; and reflexive monitoring, which assesses how staff appraise its effects once it is in use.
Three additional general items measure how "normal" the practice currently feels to users.
NoMAD has demonstrated strong validity and reliability.
|
Baseline, 12 months follow up, 24 months follow up
|
|
COPSOQ III
Time Frame: Baseline, 12 months follow up, 24 months follow up
|
The Copenhagen Psychosocial Questionnaire (COPSOQ) III is an instrument designed to measure, assess, and manage the psychosocial work environment.
The Swedish standard version of the tool evaluates 33 different dimensions of work life through 76 items, covering categories such as quantitative and emotional demands, social support, leadership quality, and health outcomes like stress and burnout.
Validated at both individual and workplace levels, the instrument demonstrates strong reliability and construct validity, making it a robust tool for identifying psychosocial risks and evaluating organizational interventions.
A key feature of its application in Sweden is the establishment of population-based benchmarks, which provide reference values that allow organizations to interpret their specific results in relation to the national average.
|
Baseline, 12 months follow up, 24 months follow up
|
|
BAT
Time Frame: Baseline, 12 months follow up, 24 months follow up
|
The Burnout Assessment Tool (BAT) is a validated, theory-based instrument for measuring work-related burnout.
It assesses four core dimensions; exhaustion, mental distance, cognitive impairment, and emotional impairment, using 23 items supported by Rasch analysis, allowing the subscales to form one reliable overall score.
The BAT performs consistently across demographic groups and enables conversion of ordinal scores into interval-level metrics, making it a precise tool for identifying burnout risk in both clinical and organizational settings.
|
Baseline, 12 months follow up, 24 months follow up
|
|
Resource use
Time Frame: January 2026- December 2028
|
January 2026- December 2028
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Elin Siira, PhD, Halmstad University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2025-03701-01
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.